Literature DB >> 24296367

Epidemiology and risk factors for idiopathic intracranial hypertension.

John Chen, Michael Wall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24296367      PMCID： PMC3864361          DOI： 10.1097/IIO.0b013e3182aabf11

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  74 in total

Review 1.  Idiopathic intracranial hypertension in men and the relationship to sleep apnea.

Authors:  Michael Wall; Valerie Purvin
Journal:  Neurology       Date:  2008-10-15       Impact factor: 9.910

2.  Endocrine studies in patients with pseudotumor cerebri. Estrogen levels in blood and cerebrospinal fluid.

Authors:  P Soelberg Sørensen; F Gjerris; B Svenstrup
Journal:  Arch Neurol       Date:  1986-09

3.  Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome.

Authors:  Y Sugita; S Iijima; Y Teshima; T Shimizu; N Nishimura; T Tsutsumi; H Hayashi; H Kaneda; Y Hishikawa
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1985-03

4.  Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension.

Authors:  Abdolreza Tabassi; Amirali Hassanzadeh Salmasi; Mahmoud Jalali
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

5.  Pseudotumor and nitrofurantoin therapy.

Authors:  G R Mushet
Journal:  Arch Neurol       Date:  1977-04

6.  Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism.

Authors:  C Van Dop; F A Conte; T K Koch; S J Clark; S L Wilson-Davis; M M Grumbach
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

7.  Indomethacin causing pseudotumor cerebri in Bartter's syndrome.

Authors:  H Konomi; M Imai; K Nihei; S Kamoshita; H Tada
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

Review 8.  All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association.

Authors:  G Visani; G Bontempo; S Manfroi; A Pazzaglia; R D'Alessandro; S Tura
Journal:  Haematologica       Date:  1996 Mar-Apr       Impact factor: 9.941

9.  Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study.

Authors:  K Radhakrishnan; A K Thacker; N H Bohlaga; J C Maloo; S E Gerryo
Journal:  J Neurol Sci       Date:  1993-05       Impact factor: 3.181

10.  Cerebrospinal fluid oestrone in pseudotumour cerebri.

Authors:  J O Donaldson; E Horak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154
View more
  30 in total

1.  Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review.

Authors:  Jason T Chisholm; Michelle M Abou-Jaoude; Amy B Hessler; Padmaja Sudhakar
Journal:  Neuroophthalmology       Date:  2017-09-01

2.  Differing presenting features of idiopathic intracranial hypertension in the UK and US.

Authors:  R J Blanch; C Vasseneix; A Liczkowski; A Yiangou; A Aojula; J A Micieli; S P Mollan; N J Newman; V Biousse; B B Bruce; A Sinclair
Journal:  Eye (Lond)       Date:  2019-02-19       Impact factor: 3.775

3.  Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.

Authors:  J Libien; M J Kupersmith; W Blaner; M P McDermott; S Gao; Y Liu; J Corbett; M Wall
Journal:  J Neurol Sci       Date:  2016-11-10       Impact factor: 3.181

Review 4.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

5.  An Ultrasound Vibro-Elastography Technique for Assessing Papilledema.

Authors:  Boran Zhou; John J Chen; Arash Kazemi; Arthur J Sit; Xiaoming Zhang
Journal:  Ultrasound Med Biol       Date:  2019-05-21       Impact factor: 2.998

Review 6.  Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine.

Authors:  Roberto De Simone; Angelo Ranieri; Mattia Sansone; Enrico Marano; Cinzia Valeria Russo; Francesco Saccà; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2019-05       Impact factor: 3.307

7.  Revised disproportionality analysis of Mirena and benign intracranial hypertension.

Authors:  Mahyar Etminan
Journal:  Ther Adv Drug Saf       Date:  2017-06-22

8.  Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.

Authors:  John J Chen; Matthew J Thurtell; Reid A Longmuir; Mona K Garvin; Jui-Kai Wang; Michael Wall; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

9.  Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity.

Authors:  Khin P Kilgore; Michael S Lee; Jacqueline A Leavitt; Bahram Mokri; David O Hodge; Ryan D Frank; John J Chen
Journal:  Ophthalmology       Date:  2017-02-07       Impact factor: 12.079

Review 10.  Idiopathic intracranial hypertension occurred after spinal surgery: report of two rare cases and systematic review of the literature.

Authors:  Zhengkuan Xu; Hao Li; Gang Chen; Fangcai Li; Shenjun Qian; Qixin Chen
Journal:  Eur Spine J       Date:  2016-05-17       Impact factor: 3.134
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.